Figure 1.
Chemical structure of the synthetic A3AR-selective agonist, CF502, used in this study. The bicyclic ring system (fused cyclopentane and cyclopropane rings) in place of the ribose moiety maintains a nucleoside conformation that is preferred in the A3AR binding site (Tchilibon, et al., 2005).